🇺🇸 FDA
Patent

US 8173158

Methods of treating gastrointestinal disorders independent of the intake of food

granted A61KA61K31/4439A61K9/5026

Quick answer

US patent 8173158 (Methods of treating gastrointestinal disorders independent of the intake of food) held by Takeda Pharmaceuticals U.S.A., Inc. expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceuticals U.S.A., Inc.
Grant date
Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/4439, A61K9/5026, A61K9/5078, A61P